Literature DB >> 18264100

Thromboxane synthase mutations in an increased bone density disorder (Ghosal syndrome).

David Geneviève1, Valérie Proulle, Bertrand Isidor, Samuel Bellais, Valérie Serre, Fatima Djouadi, Capucine Picard, Capucine Vignon-Savoye, Brigitte Bader-Meunier, Stéphane Blanche, Marie-Christine de Vernejoul, Laurence Legeai-Mallet, Anne-Marie Fischer, Martine Le Merrer, Marie Dreyfus, Pascale Gaussem, Arnold Munnich, Valérie Cormier-Daire.   

Abstract

Studying consanguineous families with Ghosal hematodiaphyseal dysplasia syndrome (GHDD), a disorder of increased bone density, we identified mutations in TBXAS1, which encodes thromboxane synthase (TXAS). TXAS, an enzyme of the arachidonic acid cascade, produces thromboxane A(2) (TXA(2)). Platelets from subjects with GHDD showed a specific deficit in arachidonic acid-produced aggregation. We also found that TXAS and TXA(2) modulated expression of TNFSF11 and TNFRSF11B (encoding RANKL and osteoprotegerin (OPG), respectively) in primary cultured osteoblasts.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18264100     DOI: 10.1038/ng.2007.66

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  19 in total

1.  Ghosal hematodiaphyseal dysplasia with myelofibrosis.

Authors:  Kalpana Datta; Madan Karmakar; Michael Hira; Sanjay Halder; Koushik Pramanik; Goutam Banerjee
Journal:  Indian J Pediatr       Date:  2012-09-15       Impact factor: 1.967

2.  Functional analysis of human thromboxane synthase polymorphic variants.

Authors:  Chung-Ying K Chen; Elizabeth M Poole; Cornelia M Ulrich; Richard J Kulmacz; Lee-Ho Wang
Journal:  Pharmacogenet Genomics       Date:  2012-09       Impact factor: 2.089

Review 3.  Ghosal hematodiaphyseal dysplasia-a concise review including an illustrative patient.

Authors:  Richa Arora; Shagun Aggarwal; Swaroopa Deme
Journal:  Skeletal Radiol       Date:  2014-08-30       Impact factor: 2.199

4.  Ghosal Hemato-diaphyseal Dysplasia: A Rare Variety of Hypoplastic Anemia with Good Response to Steroid Therapy.

Authors:  Pushpa Gurudas Kini; Sandeep Kumar; Adel Moideen; Adarsh Tulasidhar Narain
Journal:  Indian J Hematol Blood Transfus       Date:  2017-04-17       Impact factor: 0.900

5.  Novel compound heterozygous variants of TBXAS1 presenting with Ghosal hematodiaphyseal dysplasia treated with steroids.

Authors:  Sun Young Kim; Alexander Ing; Shunyou Gong; Kai Lee Yap; Rukhmi Bhat
Journal:  Mol Genet Genomic Med       Date:  2021-02-17       Impact factor: 2.183

6.  Camurati-Engelmann disease: unique variant featuring a novel mutation in TGFβ1 encoding transforming growth factor beta 1 and a missense change in TNFSF11 encoding RANK ligand.

Authors:  Michael P Whyte; William G Totty; Deborah V Novack; Xiafang Zhang; Deborah Wenkert; Steven Mumm
Journal:  J Bone Miner Res       Date:  2011-05       Impact factor: 6.741

7.  Gain-of-function mutations in the phosphatidylserine synthase 1 (PTDSS1) gene cause Lenz-Majewski syndrome.

Authors:  Sérgio B Sousa; Dagan Jenkins; Estelle Chanudet; Guergana Tasseva; Miho Ishida; Glenn Anderson; James Docker; Mina Ryten; Joaquim Sa; Jorge M Saraiva; Angela Barnicoat; Richard Scott; Alistair Calder; Duangrurdee Wattanasirichaigoon; Krystyna Chrzanowska; Martina Simandlová; Lionel Van Maldergem; Philip Stanier; Philip L Beales; Jean E Vance; Gudrun E Moore
Journal:  Nat Genet       Date:  2013-11-17       Impact factor: 38.330

Review 8.  Friend or foe: high bone mineral density on routine bone density scanning, a review of causes and management.

Authors:  Celia L Gregson; Sarah A Hardcastle; Cyrus Cooper; Jonathan H Tobias
Journal:  Rheumatology (Oxford)       Date:  2013-02-27       Impact factor: 7.580

Review 9.  The enzymology of the human prostanoid pathway.

Authors:  Roger Gregory Biringer
Journal:  Mol Biol Rep       Date:  2020-05-19       Impact factor: 2.316

Review 10.  Inherited platelet disorders: toward DNA-based diagnosis.

Authors:  Claire Lentaigne; Kathleen Freson; Michael A Laffan; Ernest Turro; Willem H Ouwehand
Journal:  Blood       Date:  2016-04-19       Impact factor: 25.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.